Yoshio Sakiyama

1.5k total citations
29 papers, 434 citations indexed

About

Yoshio Sakiyama is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Yoshio Sakiyama has authored 29 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Neurology and 6 papers in Physiology. Recurrent topics in Yoshio Sakiyama's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Lysosomal Storage Disorders Research (5 papers) and Genetic Neurodegenerative Diseases (4 papers). Yoshio Sakiyama is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Lysosomal Storage Disorders Research (5 papers) and Genetic Neurodegenerative Diseases (4 papers). Yoshio Sakiyama collaborates with scholars based in Japan and United States. Yoshio Sakiyama's co-authors include Shigeo Murayama, Yuko Saito, Hiroyuki Hatsuta, Kazutomi Kanemaru, Renpei Sengoku, Masako Ikemura, Tomio Arai, Motoji Sawabe, Genta Ito and Masashi Fukayama and has published in prestigious journals such as Journal of Endodontics, Journal of Neuropathology & Experimental Neurology and Journal of the Neurological Sciences.

In The Last Decade

Yoshio Sakiyama

25 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshio Sakiyama Japan 8 291 93 89 85 79 29 434
Nattakarn Limphaibool Poland 8 95 0.3× 62 0.7× 63 0.7× 55 0.6× 66 0.8× 18 341
Hugo Morales‐Briceño Australia 11 234 0.8× 86 0.9× 66 0.7× 30 0.4× 40 0.5× 52 349
César Tabernero Spain 9 278 1.0× 109 1.2× 65 0.7× 68 0.8× 63 0.8× 14 403
Arianna Guidubaldi Italy 11 402 1.4× 202 2.2× 31 0.3× 42 0.5× 60 0.8× 13 478
Y. K. Kim South Korea 10 155 0.5× 75 0.8× 63 0.7× 72 0.8× 26 0.3× 18 338
Elton M. Lambert United States 8 59 0.2× 30 0.3× 90 1.0× 50 0.6× 32 0.4× 30 324
Pierre Labauge France 11 172 0.6× 148 1.6× 193 2.2× 103 1.2× 52 0.7× 31 499
Philip W. Tipton United States 11 142 0.5× 69 0.7× 52 0.6× 50 0.6× 72 0.9× 44 292
Anouke van Rumund Netherlands 13 462 1.6× 133 1.4× 187 2.1× 116 1.4× 109 1.4× 19 646
Jessica Lowe United Kingdom 12 118 0.4× 61 0.7× 351 3.9× 98 1.2× 198 2.5× 22 589

Countries citing papers authored by Yoshio Sakiyama

Since Specialization
Citations

This map shows the geographic impact of Yoshio Sakiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Sakiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Sakiyama more than expected).

Fields of papers citing papers by Yoshio Sakiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Sakiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Sakiyama. The network helps show where Yoshio Sakiyama may publish in the future.

Co-authorship network of co-authors of Yoshio Sakiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Sakiyama. A scholar is included among the top collaborators of Yoshio Sakiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Sakiyama. Yoshio Sakiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matsukawa, Takashi, Akihiko Mitsutake, Yoshio Sakiyama, et al.. (2025). Clinical, neuroimaging and genetic findings in the Japanese case series of CLCN2-related leukoencephalopathy. Journal of the Neurological Sciences. 472. 123486–123486.
3.
Matsuo, Muneaki, Yoshio Sakiyama, Motomichi Kosuga, et al.. (2024). Long-term efficacy of intrathecal cyclodextrin in patients with Niemann-Pick disease type C. Brain and Development. 46(5). 207–212. 3 indexed citations
4.
Ogata, Katsuhisa, Yoko Mochizuki, Satoko Kumada, et al.. (2024). Issues of transition support to adulthood and the practices of pediatric-adult healthcare transition in neurological diseases. Rinsho Shinkeigaku. 64(7). 460–464. 1 indexed citations
5.
Namekawa, Michito, et al.. (2024). Herpes Zoster Ophthalmicus Initially Diagnosed As Cluster Headache, Complicated by Delayed Eruption. Cureus. 16(3). e56698–e56698.
6.
Ito, Kiyonori, Susumu Ookawara, Takeshi Uemura, et al.. (2023). Whole Blood Spermine/Spermidine Ratio as a New Indicator of Sarcopenia Status in Older Adults. Biomedicines. 11(5). 1403–1403. 10 indexed citations
7.
Hayashi, Yoshitaka, Yoshihide Sehara, Kenji Ohba, et al.. (2023). Therapeutic strategy for Fabry disease by intravenous administration of adeno‐associated virus 2 or 9 in α‐galactosidase A‐deficient mice. The Journal of Gene Medicine. 25(12). e3560–e3560. 4 indexed citations
8.
Mochizuki, Yoko, Katsuhisa Ogata, Satoko Kumada, et al.. (2023). Current practices of transition from pediatric to adult health care for patients with neurological disease: promote the cooperation between child and adult neurologists. Rinsho Shinkeigaku. 63(2). 67–72. 1 indexed citations
9.
10.
Ogata, Katsuhisa, Yoko Mochizuki, Toshio Saito, et al.. (2022). Perspective on transition from pediatric to adult health care for patients with neurological disease: current situation and issues. Rinsho Shinkeigaku. 62(4). 261–266. 6 indexed citations
11.
Yabe, Hiroki, Akira Ishii, Tamami Watanabe, et al.. (2014). Parsonage-Turner Syndrome Initially Suspected of Being Orthopedic Diseases in a Primary Care Setting: A Case Report. Journal of Medical Cases. 5(4). 197–201. 1 indexed citations
12.
Sakiyama, Yoshio, et al.. (2014). Abnormal copper metabolism in Niemann–Pick disease type C mimicking Wilson's disease. Neurology and Clinical Neuroscience. 2(6). 193–200. 5 indexed citations
13.
Takao, Masaki, Masahiro Aoyama, Kei‐ichi Ishikawa, et al.. (2011). Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology. BMJ Case Reports. 2011. bcr0120113685–bcr0120113685. 19 indexed citations
14.
Kurisaki, Hiroshi, et al.. (2010). An autopsy case of SCA2 with parkinsonian phenotype. Rinsho Shinkeigaku. 50(3). 156–162. 7 indexed citations
15.
Sengoku, Renpei, Yuko Saito, Masako Ikemura, et al.. (2008). Incidence and Extent of Lewy Body-Related α-Synucleinopathy in Aging Human Olfactory Bulb. Journal of Neuropathology & Experimental Neurology. 67(11). 1072–1083. 103 indexed citations
16.
Ikemura, Masako, Yuko Saito, Renpei Sengoku, et al.. (2008). Lewy Body Pathology Involves Cutaneous Nerves. Journal of Neuropathology & Experimental Neurology. 67(10). 945–953. 166 indexed citations
17.
Sakiyama, Yoshio. (2001). [Considerable supplement on the central cusp in the lower second molar].. PubMed. 76(4). 407–10. 2 indexed citations
18.
Nagasawa, S, et al.. (1991). Teratogenic characteristics by single dosing of antineoplastic platinum complexes in rats : Abstracts of Papers Presented at the Thirty-First Annual Meeting of the Japanese Teratology Society Izumo, Japan, July 11-12, 1991. Congenital Anomalies. 31(3). 222–223. 1 indexed citations
19.
Sakiyama, Yoshio, et al.. (1989). A maxillary central incisor having two root canals geminated with a supernumerary tooth. Journal of Endodontics. 15(4). 161–163. 25 indexed citations
20.
Mori, Masahiko & Yoshio Sakiyama. (1969). The enzyme histochemistry of developing odontoblasts in cattle, pigs and horses. The Histochemical Journal. 1(4). 281–294. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nattakarn Limphaibool Breakdown of academic impact, for papers by Hugo Morales‐Briceño Breakdown of academic impact, for papers by César Tabernero Breakdown of academic impact, for papers by Arianna Guidubaldi Breakdown of academic impact, for papers by Y. K. Kim Breakdown of academic impact, for papers by Elton M. Lambert Breakdown of academic impact, for papers by Pierre Labauge Breakdown of academic impact, for papers by Philip W. Tipton Breakdown of academic impact, for papers by Anouke van Rumund Breakdown of academic impact, for papers by Jessica Lowe
Rankless by CCL
2026